Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cheelcare Inc. ( (TSE:CHER) ) has issued an announcement.
Cheelcare Inc. has appointed Dave Jones as Director of U.S. Sales to spearhead its expansion in the American market. With over 30 years of experience in the rehabilitation and medical equipment sectors, Jones will focus on expanding Cheelcare’s dealer and clinical network, particularly for the Companion power-assist device and the Curio robotic wheelchair. The recent update in CMS coding will facilitate reimbursement, enhancing product accessibility and market penetration in the U.S.
More about Cheelcare Inc.
Cheelcare Inc. is a Canadian company specializing in assistive mobility devices. It designs and manufactures innovative solutions aimed at empowering independence for people with disabilities, including the Companion power assist devices and the Curio robotic wheelchair.
Average Trading Volume: 35,878
Technical Sentiment Signal: Buy
For an in-depth examination of CHER stock, go to TipRanks’ Overview page.